Strategies for FutureMed: Internal, External, Marketing and Technology Perspectives

Dynamic Strategy
and Disruptive
Innovation

Internal perspective (Section A)
 FutureMed produces
pharmaceuticals drugs
 There is no systematic
method for the
identification or formation
of possible disruptive
technologies to increase
the efficiency

Background Information (Section A)
 Conservative internal culture
 Senior management can’t
adopt change
 Allocation based profitability
not future focused
 Old staffs in senior
management team
 Organizational culture has
traditional rigid

Factors of Internal perspectives
(Section A) The senior management team is
conjured of each of the company’s
great subdivisions including
marketing,
finance,
operations,
research and development
(Moffat et al., 2011).

Recommendation (Section A)
 Australian Department of
Health administered new
pharmaceuticals for being
registered on the Australian
Register of Therapeutic Goods
(ARTG) to be legally provided
in different country of
Australia.

Section B) External perspective
 governmental legislations are effecting
the business expansion process of
FutureMed.
 In this manner, the commitment of the
senior management is playing an
essential role in the external
perspective for the business expansion
process of FutureMed in Australia